title: Cervical cancer screening in France.
abstract: In France, as in other European countries the incidence and mortality rates of carcinoma of the cervix uteri indicate a clear decrease in invasive cancers. Opportunistic screening has spread and, presently, approximately 60% of the female population undergo a regular cytological test. This rate increases up to 80% in the younger age groups and decreases to 20% after the age of 60 years. In 1990, intervention procedures were defined at a consensus conference; the major recommendations were to screen all women exclusively by cervical smears, for ages 25-65 years over a 3-year period. Guidelines on the quality control of cervical smear taking and reading were published by the national agency of evaluation of health intervention (ANAES). Since 1990, four population-based, organised pilot programmes, have been implemented in Isère. Doubs, Bas-Rhin and Martinique. These programmes evaluate the participation rate (from approximately 20-80% depending upon the age and the geographical area), the rate of abnormal tests (0.2-3%), according to the laboratories, the cancer detection rate (0.04%-0.15%) and some other quality indicators. Recently (November 1998) a law was passed stipulating that the screening test will be free of charge when performed in agreement with the national recommendations. A specific organisation for cytological quality control will be implemented. An effort to better identify and to include the screening process the women in the population who are not yet participating has to be made.
authors.affiliation: Programme EVE, Strasbourg, France.
authors.forename: P
authors.initials: P
authors.lastname: Schaffer
authors.forename: H
authors.initials: H
authors.lastname: Sancho-Garnier
authors.forename: M
authors.initials: M
authors.lastname: Fender
authors.forename: P
authors.initials: P
authors.lastname: Dellenbach
authors.forename: J P
authors.initials: JP
authors.lastname: Carbillet
authors.forename: E
authors.initials: E
authors.lastname: Monnet
authors.forename: G P
authors.initials: GP
authors.lastname: Gauthier
authors.forename: A
authors.initials: A
authors.lastname: Garnier
mesh_terms: D000328:Adult; D017677:Age Distribution; D000368:Aged; D005260:Female; D005602:France / Q000453:epidemiology; D006801:Humans; D008403:Mass Screening / Q000458:organization & administration* / Q000592:standards; D008875:Middle Aged; D011785:Quality Assurance, Health Care / Q000458:organization & administration; D012017:Referral and Consultation; D012042:Registries; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000517:prevention & control*; D014626:Vaginal Smears / Q000379:methods